| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |